MENLO PARK, Calif.–(BUSINESS WIRE)–Personalis, Inc. (Nasdaq: PSNL) today announced a collaboration with Sarepta Therapeutics (Nasdaq: …
Read More »
INDIANAPOLIS, May 28, 2020 /PRNewswire/ — TAUVID™, a radioactive diagnostic agent, has been approved by the FDA for …
Read More »
Basel, 04 June 2020 – Roche (SIX: RO, ROG; OTCQX: RHHBY) announced today that the …
Read More »
Last year, 2016, brought a whirlwind of changes and progress to the hepatitis C field, …
Read More »
THOUSAND OAKS, Calif., June 13, 2016 /PRNewswire/ — Amgen (NASDAQ:AMGN) today announced that the Arthritis …
Read More »
NORTHBROOK, Ill.–(BUSINESS WIRE)–Marathon Pharmaceuticals, LLC, a biopharmaceutical company developing treatments for rare diseases, today announced …
Read More »
With drug development costs topping $1.2bn (£850 million) to get a single treatment to the …
Read More »
CAMBRIDGE, Mass.–(BUSINESS WIRE)–Eleven Biotherapeutics, Inc. (NASDAQ:EBIO), a biopharmaceutical company discovering and developing protein therapeutics to treat …
Read More »
(WASHINGTON –June 13, 2016) – New research published online today in Blood, the Journal of the …
Read More »
DURHAM, N.C., June 13, 2016 (GLOBE NEWSWIRE) — Argos Therapeutics Inc. (Nasdaq:ARGS), an immuno-oncology company …
Read More »
San Diego, Calif. – Malignant neuroendocrine tumors (NETs) are relatively rare, notoriously difficult to treat, …
Read More »
Lexington, Mass. – June 13, 2016 – Shire plc (LSE: SHP, NASDAQ: SHPG) today announced …
Read More »
ROCKVILLE, Md.–(BUSINESS WIRE)–GlycoMimetics, Inc. (NASDAQ:GLYC) today announced that it received Fast Track designation from the …
Read More »
MD Anderson News Release 06/12/2016 — In a randomized Phase III study of the drug inotuzumab …
Read More »
Kalamazoo, Michigan – OptiMed Specialty Pharmacy, a privately-held specialty pharmacy headquartered in Kalamazoo, Michigan, announced …
Read More »
The U.S. Food and Drug Administration, in partnership with international regulatory and law enforcement agencies, …
Read More »
THOUSAND OAKS, Calif., June 10, 2016 /PRNewswire/ — Amgen (NASDAQ: AMGN) today announced new data …
Read More »
LONDON, June 10, 2016 /PRNewswire/ — Reduction of weight limit to at least 30kg means …
Read More »
KENILWORTH, N.J. & SAN MATEO, Calif., June 9, 2016 – Merck (NYSE:MRK), known as MSD …
Read More »
Specialty Pharma Journal Specialty, Precision & Technology
